| scholarly article | Q13442814 |
| P2093 | author name string | Qing Jiang | |
| Chao Yang | |||
| P2860 | cites work | De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling | Q24299573 |
| ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB | Q24336707 | ||
| Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice | Q24616207 | ||
| Immunity, Inflammation, and Cancer | Q27861048 | ||
| CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members | Q28201693 | ||
| Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB | Q28201706 | ||
| NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway | Q28269436 | ||
| Introduction to NF-kappaB: players, pathways, perspectives | Q28271022 | ||
| Gamma-tocotrienol attenuates the aberrant lipid mediator production in NLRP3 inflammasome-stimulated macrophages | Q89344758 | ||
| Targeting NF-kappaB in hematologic malignancies | Q28299055 | ||
| NF-kappaB functions as a tumour promoter in inflammation-associated cancer | Q29614598 | ||
| The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses | Q29616349 | ||
| Crosstalk in NF-κB signaling pathways | Q29617418 | ||
| Inflammation and oncogenesis: a vicious connection | Q33653294 | ||
| Oncogenic activation of NF-kappaB. | Q33849388 | ||
| Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy | Q33998131 | ||
| Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. | Q34277639 | ||
| δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens | Q34646385 | ||
| Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer | Q35613168 | ||
| The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer | Q35687935 | ||
| Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin | Q35704170 | ||
| Vitamin E γ-Tocotrienol Inhibits Cytokine-Stimulated NF-κB Activation by Induction of Anti-Inflammatory A20 via Stress Adaptive Response Due to Modulation of Sphingolipids | Q35762884 | ||
| Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide. | Q36052937 | ||
| Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry | Q36127968 | ||
| Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells | Q36157119 | ||
| Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. | Q36164605 | ||
| A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia | Q36437690 | ||
| Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells | Q36482246 | ||
| γ-Tocotrienol inhibits lipopolysaccharide-induced interlukin-6 and granulocyte colony-stimulating factor by suppressing C/EBPβ and NF-κB in macrophages | Q36724490 | ||
| Vitamin E metabolite 13'-carboxychromanols inhibit pro-inflammatory enzymes, induce apoptosis and autophagy in human cancer cells by modulating sphingolipids and suppress colon tumor development in mice | Q36902001 | ||
| NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy | Q37391444 | ||
| CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes | Q37448141 | ||
| The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology | Q37567071 | ||
| gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis | Q37707881 | ||
| Return to homeostasis: downregulation of NF-κB responses | Q37902868 | ||
| CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different | Q39210955 | ||
| Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells | Q39259261 | ||
| Dihydroceramide desaturase activity is modulated by oxidative stress. | Q39747371 | ||
| Direct, noncatalytic mechanism of IKK inhibition by A20. | Q39773165 | ||
| The deubiquitinase activity of A20 is dispensable for NF-κB signaling. | Q42076015 | ||
| Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity | Q45018412 | ||
| A20 attenuates allergic airway inflammation in mice. | Q45954119 | ||
| Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells. | Q46036649 | ||
| Natural Forms of Vitamin E as Effective Agents for Cancer Prevention and Therapy | Q49988596 | ||
| TNF phase III signalling in tolerant cells is tightly controlled by A20 and CYLD. | Q50577547 | ||
| Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment. | Q51027990 | ||
| Annatto Tocotrienol Attenuates NLRP3 Inflammasome Activation in Macrophages | Q89335918 | ||
| P921 | main subject | sphingolipids | Q410395 |
| NF-κB | Q411114 | ||
| P304 | page(s) | 101-109 | |
| P577 | publication date | 2018-11-03 | |
| P1433 | published in | Journal of Nutritional Biochemistry | Q15716705 |
| P1476 | title | Vitamin E δ-tocotrienol inhibits TNF-α-stimulated NF-κB activation by up-regulation of anti-inflammatory A20 via modulation of sphingolipid including elevation of intracellular dihydroceramides | |
| P478 | volume | 64 |
Search more.